NCT04551716View on ClinicalTrials.gov

Noninvasive Assessment of Metabolic Associated Fatty Liver Disease (MAFLD) in Chinese Population

CompletedOBSERVATIONAL
Enrollment

448

Participants

Timeline

Start Date

September 10, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

August 31, 2022

Conditions
Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)
Trial Locations (1)

100853

Chinese PLA General Hospital, Beijing

All Listed Sponsors
lead

Chinese PLA General Hospital

OTHER

NCT04551716 - Noninvasive Assessment of Metabolic Associated Fatty Liver Disease (MAFLD) in Chinese Population | Biotech Hunter | Biotech Hunter